Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index; 47 of the 79 sources its claims cite were checked for support.
Abstract
Background: Polycystic ovary syndrome (PCOS) has been associated with a high prevalence of obstructive sleep apnea syndrome (OSAS). However, the impact of OSAS on the PCOS symptom profile remains unclear. This systematic review and meta-analysis, which informed the 2023 International Evidence-based PCOS Guideline, aims to assess the prevalence and related symptoms of OSAS among females with and without PCOS. Methods: A systematic search using databases (MEDLINE, Embase, EBM Reviews, PsycInfo and CINAHL) was performed until 16 th May 2024. Random-effects restricted maximum likelihood meta-analyses compared OSAS and related symptoms between PCOS and non-PCOS groups. OSAS outcomes were categorized as apnea-hypopnea index (AHI)≥5 only, AHI≥5 with symptoms, AHI≥10 with symptoms and composite OSA (i.e., all AHI cut-offs with and/or without symptoms). Subgroup analyses by body mass index (BMI), age, PCOS diagnostic criteria and ethnicity were performed. Risk of bias and certainty of evidence by the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework were conducted. Results: From 4438 records, 3205 titles/abstracts were screened and 40 were eligible for full-text screening. Eight cross-sectional studies met inclusion criteria and meta-analysis. The pooled prevalence of OSA was 37.0% in PCOS (29.0% adolescents; 40.0% adults) and 6.0% in non-PCOS. Compared with non-PCOS, those with PCOS showed higher risk for composite OSA (odds ratio (OR): 9.52; 95% CI: 3.90 to 23.26; I2 = 54.5%; 8 studies, n=942; P<0.001) and more pronounced OSAS risk with increasing symptom severity in PCOS (AHI≥5 OR: 3.90; 95% CI: 1.63 to 9.34; AHI≥5 with symptoms OR: 17.95; 95% CI: 6.17 to 52.22; AHI≥10 with symptoms OR: 30.61; 95% CI: 7.99 to 117.25, all P ≤ 0.0023). Subgroup results showed significantly higher risk of OSAS overall in overweight/obesity, adults and white ethnicity compared with normal weight, adolescent and Asian subgroups, respectively (all P<0.001), but independent of PCOS diagnostic criteria. Conclusion: The prevalence of OSA was higher in PCOS compared with non-PCOS groups, with the risk of OSAS increasing with worse symptom severity. Adults and those of higher BMI and of white ethnicity were at increased risk of OSAS. Hence, identifying and treating OSAS symptoms in PCOS may be beneficial, but further validation of findings is warranted.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis found that obstructive sleep apnea (OSA) is substantially more prevalent and more likely in females with polycystic ovary syndrome (PCOS) than in non-PCOS controls, with risk increasing as OSAS symptom severity increases. The findings informed the 2023 International Evidence-based PCOS Guideline and support screening for OSAS symptoms in PCOS, though the authors call for further validation.
Key findings
- Pooled OSA prevalence was 37.0% in PCOS (29.0% adolescents; 40.0% adults) versus 6.0% in non-PCOS; non-PCOS adolescent and adult prevalence were both 7.0% in the discussion.
- Composite OSA risk was higher in PCOS: OR 9.52 (95% CI 3.90–23.26; I² = 54.5%; 8 studies, n = 942; P < 0.001).
- Risk was more pronounced with greater OSAS symptom severity: AHI ≥5 only OR 3.90 (95% CI 1.63–9.34), AHI ≥5 with symptoms OR 17.95 (95% CI 6.17–52.22), and AHI ≥10 with symptoms OR 30.61 (95% CI 7.99–117.25).
- Subgroup analyses showed significantly higher OSAS risk in overweight/obesity, adults, and white ethnicity compared with normal weight, adolescent, and Asian subgroups, respectively (all P < 0.001), but findings were largely independent of PCOS diagnostic criteria.
Methods
- Systematic review and meta-analysis registered in PROSPERO and reported per PRISMA; databases MEDLINE, Embase, EBM Reviews, PsycInfo, and CINAHL were searched up to 16 May 2024.
- Included 8 controlled cross-sectional studies with clinically confirmed PCOS, non-PCOS controls, and formal sleep studies (PSG/polygraph); total participants were 280 with PCOS and 662 without PCOS.
- Random-effects restricted maximum likelihood meta-analyses compared OSAS outcomes categorized as composite OSA, AHI ≥5 only, AHI ≥5 with symptoms, and AHI ≥10 with symptoms; subgroup analyses examined BMI, age, PCOS diagnostic criteria, and ethnicity, with risk of bias and GRADE assessments.
Limitations
- Stated by the authors: included studies had moderate to high risk of bias due to detection and selection biases; pooled sample sizes were relatively small; there was variable adjustment for confounders such as age, BMI, and ethnicity; BMI distribution and OSA definitions/assessment methods were heterogeneous; ethnic and geographic groups were under-represented; and single-paper or one-study subgroup analyses should be interpreted cautiously.
- Evident from the text: all included studies were cross-sectional, with no RCTs identified; publication bias was observed for overall OSA prevalence in both PCOS and non-PCOS populations based on funnel plot asymmetry; GRADE certainty was low for composite OSA and moderate for the other OSAS symptom categories.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
24 Valid · 3 Not valid · 11 Not checked · 77 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Regarding differences by diagnostic criteria, we found significantly higher risks of OSAS in PCOS overall compared with those without PCOS, regardless of diagnostic criteria (45).”
§ Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis > Discussion
What the sources say
- Could not verifycites [45] Kang, 2013, Associations between adenotonsillar hypertrophy, age, and obesity in children with obstructive sleep apnea, PloS One sourceExperimental — accuracy not yet measured
The Results (Multivariable regression model; page unavailable) assess OSA risk in children by obesity and adenotonsillar hypertrophy. Searches for PCOS and diagnostic criteria found no passage comparing OSA risk in people with and without PCOS, so this copy does not address the attributed finding. (LLM, conf=0.78)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“It should be noted that despite prior meta-analysis reporting worse metabolic parameters (e.g., insulin resistance) in those with PCOS and OSAS compared to without OSAS (26), other common mechanistic factors like hyperandrogenism and insulin resistance linking PCOS and OSAS were not invariably measured independently of confounders like BMI.”
§ Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis > Discussion
What the sources say
- Supportedcites [26] He, 2024, Polycystic ovary syndrome in obstructive sleep apnea-hypopnea syndrome: an updated meta-analysis, Front Endocrinol source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“with only five of the eight studies having adjusted or matched their control group by age, BMI and/or ethnicity (15, 17, 18, 21, 40).”
§ Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis > Results > Meta-analysis
What the sources say
- Not checked — no full text of the sourcecites [15] Fogel, 2001, Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome, J Clin Endocrinol Metab source
- Supportedcites [17] Tasali, 2008, Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome, J Clin Endocrinol Metab source
The Statistical analysis section states that comparisons between women with PCOS and controls were adjusted for age, BMI, and ethnicity. This supports citing the paper as one of the studies that adjusted for those factors; the count of five among eight studies is the citing authors’ synthesis, not a count attributed to this individual paper. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [18] Suri, 2016, Obesity may be the common pathway for sleep-disordered breathing in women with polycystic ovary syndrome, Sleep Med source
- Supportedcites [21] Nandalike, 2012, Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome, Sleep Med source
The Methods (Study Population, Controls) state that the paper used control groups matched by age and BMI Z-score. This supports citing it as one of the studies with matched controls; the count of five among eight studies is the citing authors’ synthesis, not a finding attributed to this individual paper. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [40] Yang, 2009, Apnea–hypopnea index in nonobese women with polycystic ovary syndrome, Int J Gynaecol Obstet source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Past cross-sectional studies have shown that OSAS is highly prevalent in women with PCOS (15–19) compared with the general population of reproductive-aged women (17-75% vs. 9-28%) (9, 10), with lower rates in adolescents with PCOS (0-57%) (20, 21).”
§ Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis > Introduction
What the sources say
- Not checked — no full text of the sourcecites [15] Fogel, 2001, Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [16] Vgontzas, 2001, Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance, J Clin Endocrinol Metab source
- Supportedcites [17] Tasali, 2008, Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome, J Clin Endocrinol Metab source
The Results report OSA in 56% of women with PCOS versus 19% of women without PCOS, supporting the high-prevalence comparison attributed to this paper. The 17–75% range covers this study’s 56% finding; the citing sentence assigns the general-population range to different citations. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [18] Suri, 2016, Obesity may be the common pathway for sleep-disordered breathing in women with polycystic ovary syndrome, Sleep Med source
- Supportedcites [19] Hachul, 2019, Sleep disorders in polycystic ovary syndrome: influence of obesity and hyperandrogenism, Rev Assoc Med Bras source
The Introduction states that OSA prevalence is increased in women with PCOS compared with women without PCOS, and the Results report more OSA in the PCOS group than in controls. The numerical ranges in the citing sentence are attached to other citations, not this paper. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [9] Young, 2002, Epidemiology of obstructive sleep apnea: a population health perspective, Am J Respir Crit Care Med source
- Not checked — no full text of the sourcecites [10] Jonas, 2017 source
- Supportedcites [20] de Sousa, 2011, Relationships between polysomnographic variables, parameters of glucose metabolism, and serum androgens in obese adolescents with polycystic ovarian syndrome, J Sleep Res source
In the citing sentence, this paper is cited for the lower OSAS rate in adolescents with PCOS, not for the adult prevalence percentages. The Results report no OSAS cases among 31 adolescents with PCOS, and the Discussion says OSAS does not seem frequent in this group. The paper does not establish the quoted adult percentage ranges, which the citing sentence attributes to other references. (LLM, conf=0.88)
- Partly supportedcites [21] Nandalike, 2012, Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome, Sleep Med sourceExperimental — accuracy not yet measured
The Abstract Results report OSA in 57% of the adolescent girls with PCOS studied, supporting the upper end of the adolescent range for which this paper is cited. The Discussion describes a prior adolescent study that did not find increased prevalence, but our copy does not give a 0% rate or establish that rates in adolescents are generally lower than in adults. This study involved obese adolescents referred for sleep evaluation, not adolescents with PCOS generally. (LLM, conf=0.84)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Moreover, there was moderate evidence certainty for OSAS outcomes; AHI ≥5 only, AHI ≥5 with symptoms and AHI ≥10 with symptoms, again downgraded either once for serious imprecision (20, 40) or for serious risk of bias.”
§ Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis > Results > Quality assessment and grading
What the sources say
- Could not verifycites [20] de Sousa, 2011, Relationships between polysomnographic variables, parameters of glucose metabolism, and serum androgens in obese adolescents with polycystic ovarian syndrome, J Sleep Res sourceExperimental — accuracy not yet measured
The Polysomnography section defines OSAS using AHI ≥5, and the Results report that no participant met that threshold. Our copy does not assess certainty of evidence for the three stated OSAS outcomes or discuss downgrading for imprecision or risk of bias (searched: certainty of evidence, symptoms, imprecision, risk of bias). (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [40] Yang, 2009, Apnea–hypopnea index in nonobese women with polycystic ovary syndrome, Int J Gynaecol Obstet source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
70 more claims · 11 with their cited sources checked
Create a free account to see all 115 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 23
- Probably not a substantial claim. 22
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 1×
“We also assessed the certainty of the evidence at the outcome-level using the validated GRADE framework (33).”
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329 · cited 1×
“As no RCTs were identi fi ed, quality appraisal was conducted using templates adapted from the Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) tool (32).”
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364 · cited 1×
“Using ESS, participants were asked to rate their probability offalling asleep in eight different situations on a scale of 0 (not likely at all) to 3 (extremely likely) (31).”
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138 · cited 1×
“…in adults is based on the presence of two of three features: (i) oligo/ amenorrhea; (ii) clinical/biochemical hyperandrogenism and/or (iii) polycystic ovary morphology (4) or elevated serum anti-Müllerian hormone levels, according to the latest 2023 International Evidence-based PCOS Guideline (1).”
Epidemiology of Obstructive Sleep Apnea: A Population Health Perspective
Young, T., Peppard, P. E., & Gottlieb, D. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109080 · Cited by 4,244 · cited 2×
“(9, 10), with lower rates in adolescents with PCOS (0-57”
Publication Bias in Meta‐Analysis: Prevention, Assessment and Adjustments
(2005) · doi:10.1002/0470870168 · Cited by 2,368
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Self-citation
Research works printed but not linked: 2
- Global InfoBase team, 2005, The SuRF Report 2. Surveillance of chronic disease Risk Factors: Country-level data and comparable estimates
- 2023, Stata statistical software: release 18. College station
Cited by
Li, N., Yang, R. J., Zhao, Y., Wang, Y., Tang, Q., Li, J., Huang, Y., Huang, Y., Zhang, L., Wang, Y., et al. (2025) · Sleep And Breathing · doi:10.1007/s11325-025-03399-9 · Cited by 5
Capozzi, A., Scambia, G., Driul, L., Vignali, M., & Lello, S. (2025) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.25.05746-x · Cited by 9
A case control study of subjective sleep characteristics and polycystic ovary syndrome
Zhuang, X., Zhang, S., Fu, R., Cai, C., Yin, J., Shi, W., Cen, J., & Ji, X. (2026) · Scientific Reports · doi:10.1038/s41598-026-50477-3 · Cited by 1
“Moreover, existing research on the relationship between sleep and PCOS has predominantly focused on obesity-related obstructive sleep apnoea (OSA), making it difficult to disentangle the association from obesity as a confounder 26 .”
Rating Scales for Obstructive Sleep Apnea Syndrome: The Importance of a Comprehensive Assessment
Bordoni, B., & Morabito, B. (2026) · Cureus · doi:10.7759/cureus.100725
“Probably, there is an overlap with other pathologies, such as diabetes, obesity and hypertension, and it is not easy to discriminate the initial cause of this finding [101].”
VELA, A. M., Delity, M., Johnson, R. L., DuBose, L. E., Epperson, C. N., & Phimphasone‐Brady, P. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101528 · Cited by 1
“[11].”
Metadata
- Authors
- Abdul Jafar, N. K., Al Balushi, A., Subramanian, A., Lee, S. I., Bennett, C. J., Moran, L. J., Mousa, A., Tay, C. T., Teede, H. J., & Mansfield, D. R.
- Affiliations
- University of Birmingham (GB)
- Monash University (AU)
- Monash Medical Centre (AU)
- Corresponding author
- Mansfield, Darren R.
- ORCID
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2025-04-04
- Volume
- 16
- Pages
- 1532519-1532519
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC12006010
- OpenAlex
- W4409167502
- Cited by
- 15
- References
- 44
- Citations by year
- 2026: 13 · 2025: 2
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Veski
- Australian Government
- Medical Research Council
- National Health and Medical Research Council (1171592)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- obstructive sleep apnea, polycystic ovary syndrome, prevalence, apnea-hypopnea index, body mass index, adolescents, adults, ethnicity, PCOS diagnostic criteria, comorbidities, sleep-disordered breathing, insulin resistance, hyperandrogenism
- MeSH terms
- Female, Humans, Polycystic Ovary Syndrome, Body Mass Index, Prevalence, Sleep Apnea, Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.3389/fendo.2025.1532519
- The paper
- Abdul Jafar, N. K., Al Balushi, A., Subramanian, A., Lee, S. I., Bennett, C. J., Moran, L. J., Mousa, A., Tay, C. T., Teede, H. J., & Mansfield, D. R. (2025). Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2025.1532519
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.